2489 related articles for article (PubMed ID: 28215162)
1. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases.
Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A
Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162
[TBL] [Abstract][Full Text] [Related]
2. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
4. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
Spielman LJ; Gibson DL; Klegeris A
Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
[TBL] [Abstract][Full Text] [Related]
5. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.
Cani PD; Plovier H; Van Hul M; Geurts L; Delzenne NM; Druart C; Everard A
Nat Rev Endocrinol; 2016 Mar; 12(3):133-43. PubMed ID: 26678807
[TBL] [Abstract][Full Text] [Related]
7. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
8. Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis.
Farzi A; Hassan AM; Zenz G; Holzer P
Mol Aspects Med; 2019 Apr; 66():80-93. PubMed ID: 30513310
[TBL] [Abstract][Full Text] [Related]
9. Gut brain axis: an insight into microbiota role in Parkinson's disease.
Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M
Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175
[TBL] [Abstract][Full Text] [Related]
10. The role of the microbiome for human health: from basic science to clinical applications.
Mohajeri MH; Brummer RJM; Rastall RA; Weersma RK; Harmsen HJM; Faas M; Eggersdorfer M
Eur J Nutr; 2018 May; 57(Suppl 1):1-14. PubMed ID: 29748817
[TBL] [Abstract][Full Text] [Related]
11. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
12. The Local Defender and Functional Mediator: Gut Microbiome.
Yang H; Duan Z
Digestion; 2018; 97(2):137-145. PubMed ID: 29310114
[TBL] [Abstract][Full Text] [Related]
13. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiota and its correlations with the central nervous system disorders.
Catanzaro R; Anzalone M; Calabrese F; Milazzo M; Capuana M; Italia A; Occhipinti S; Marotta F
Panminerva Med; 2015 Sep; 57(3):127-43. PubMed ID: 25390799
[TBL] [Abstract][Full Text] [Related]
15. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
Petra AI; Panagiotidou S; Hatziagelaki E; Stewart JM; Conti P; Theoharides TC
Clin Ther; 2015 May; 37(5):984-95. PubMed ID: 26046241
[TBL] [Abstract][Full Text] [Related]
16. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication.
Silva YP; Bernardi A; Frozza RL
Front Endocrinol (Lausanne); 2020; 11():25. PubMed ID: 32082260
[TBL] [Abstract][Full Text] [Related]
17. The Role of the Gastrointestinal Microbiota in Visceral Pain.
Rea K; O'Mahony SM; Dinan TG; Cryan JF
Handb Exp Pharmacol; 2017; 239():269-287. PubMed ID: 28035535
[TBL] [Abstract][Full Text] [Related]
18. Role of microbiota-derived short-chain fatty acids in nervous system disorders.
Mirzaei R; Bouzari B; Hosseini-Fard SR; Mazaheri M; Ahmadyousefi Y; Abdi M; Jalalifar S; Karimitabar Z; Teimoori A; Keyvani H; Zamani F; Yousefimashouf R; Karampoor S
Biomed Pharmacother; 2021 Jul; 139():111661. PubMed ID: 34243604
[TBL] [Abstract][Full Text] [Related]
19. The role of the gut microbiota in development, function and disorders of the central nervous system and the enteric nervous system.
Heiss CN; Olofsson LE
J Neuroendocrinol; 2019 May; 31(5):e12684. PubMed ID: 30614568
[TBL] [Abstract][Full Text] [Related]
20. Palmitoylethanolamide counteracts autistic-like behaviours in BTBR T+tf/J mice: Contribution of central and peripheral mechanisms.
Cristiano C; Pirozzi C; Coretti L; Cavaliere G; Lama A; Russo R; Lembo F; Mollica MP; Meli R; Calignano A; Mattace Raso G
Brain Behav Immun; 2018 Nov; 74():166-175. PubMed ID: 30193877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
